Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.22.0.1
Revenue from Contracts with Customers (Tables)
3 Months Ended
Dec. 31, 2021
Revenue from Contracts with Customers [Abstract]  
Revenue from Customers by Products Three Months Ended December 31, 2021 2020FC2 U.S. prescription channel$ 11,574,266 $ 9,101,739Global public health sector 2,560,866 4,652,419Total FC2 14,135,132 13,754,158PREBOOST® — 862,831Net revenues$ 14,135,132 $ 14,616,989
Revenue by Geographic Area Three Months Ended December 31, 2021 2020 United States$ 11,908,525 $ 10,355,838Other 2,226,607 4,261,151Net revenues$ 14,135,132 $ 14,616,989